BeiGene Stock Bearish By 9% So Far Today
BeiGene (NASDAQ: BGNE), an oncology-focused biotechnology firm, experienced an alarming decline on Wednesday’s trading session – dropping 9.52 percent and contributing to an overall decrease of 1.98 percent on NASDAQ. BeiGene has now experienced three consecutive sessions of losses. BeiGene’s Unprecedented Decrease BeiGene has experienced an astonishing 26.4% decrease from their 52-week high of $374.62,…